These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15980367)

  • 21. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity of fluoroquinolone-nonsusceptible Streptococcus pneumoniae clinical isolates and the first identification of serotype 20B in China.
    Guo Q; Zhuo C; Xu Y; Huang W; Wang C; Zhang S; Huang J; Hu F; Zhu D; Yang F; Wang M
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):465-70. PubMed ID: 24091745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.
    Kasahara K; Maeda K; Mikasa K; Uno K; Takahashi K; Konishi M; Yoshimoto E; Murakawa K; Kita E; Kimura H
    J Clin Microbiol; 2005 Apr; 43(4):1640-5. PubMed ID: 15814978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
    Sunagawa S; Fujita J; Higa F; Tateyama M; Haranaga S; Nakasone I; Yamane N; Uno T
    J Antibiot (Tokyo); 2011 Aug; 64(8):539-45. PubMed ID: 21587266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
    Shin JH; Jung HJ; Kim HR; Jeong J; Jeong SH; Kim S; Lee EY; Lee JN; Chang CL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2625-7. PubMed ID: 17502407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
    Ardanuy C; Rolo D; Fenoll A; Tarrago D; Calatayud L; Liñares J
    J Antimicrob Chemother; 2009 Sep; 64(3):507-10. PubMed ID: 19535383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates.
    Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2001 Nov; 18(5):433-6. PubMed ID: 11711257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
    Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
    J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic-resistant invasive pneumococcal clones in Italy.
    Gherardi G; Fallico L; Del Grosso M; Bonanni F; D'Ambrosio F; Manganelli R; Palù G; Dicuonzo G; Pantosti A
    J Clin Microbiol; 2007 Feb; 45(2):306-12. PubMed ID: 17122014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolide resistance in Streptococcus pneumoniae: clonality and mechanisms of resistance in 24 countries.
    Bozdogan B; Bogdanovich T; Kosowska K; Jacobs MR; Appelbaum PC
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):169-76. PubMed ID: 15379728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.
    Dias R; Caniça M
    J Antimicrob Chemother; 2004 Dec; 54(6):1035-9. PubMed ID: 15531597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001.
    Davies TA; Yee YC; Goldschmidt R; Sahm DF; Evangelista AT
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):39-45. PubMed ID: 18931470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
    Adam HJ; Schurek KN; Nichol KA; Hoban CJ; Baudry TJ; Laing NM; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.
    van der Linden M; Al-Lahham A; Haupts S; Reinert RR
    Antimicrob Agents Chemother; 2007 May; 51(5):1830-4. PubMed ID: 17325214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes.
    Ko KS; Song JH
    J Infect Dis; 2004 Aug; 190(4):739-47. PubMed ID: 15272402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.